Aclaris Therapeutics (ACRS) Return on Sales Growth (1y) (2018 - 2026)

Aclaris Therapeutics (ACRS) Return on Sales Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (1y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 0.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 0.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 0.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Aclaris Therapeutics 687.20 Mn 581.79 Mn 1.60 Mn -6.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.00
Dec 31, 2025 -12.00
Sep 30, 2025 -4.00
Jun 30, 2025 -6.00
Mar 31, 2025 -5.00
Dec 31, 2024 -12.00
Sep 30, 2024 1.00
Jun 30, 2024 17.00
Mar 31, 2024 6.00
Dec 31, 2023 27.00
Sep 30, 2023 -2.00
Jun 30, 2023 0.00
Mar 31, 2023 13.00
Dec 31, 2022 96.00
Sep 30, 2022 21.00
Jun 30, 2022 -2.00
Mar 31, 2022 8.00
Dec 31, 2021 -123.00
Sep 30, 2021 -23.00
Jun 30, 2021 -19.00